Work

Improvements in Health-Related Quality of Life for Patients Treated with LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy

Year: 2020

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2020-136193

Authors: Julie Kanter, John F. Tisdale, Markus Y Mapara, Janet L. Kwiatkowski, Lakshmanan Krishnamurti, Ren Chen, Meghan E. Gallagher, Yuchen Ding, Sunita Goyal, Clark Paramore, Alexis A. Thompson, Mark C. Walters

Institutions: University of Alabama at Birmingham, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute, Columbia University, Children's Hospital of Philadelphia, University of Pennsylvania, Emory University, Children's Healthcare of Atlanta, Bluebird Bio (United States), Northwestern University, Lurie Children's Hospital, UCSF Benioff Children's Hospital

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097296548

Cites:

Cited by: 8

Related to: 10